FLUDARA

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

FLUDARABINE PHOSPHATE 50 MG/VIAL

Dostupné s:

SANOFI - AVENTIS ISRAEL LTD

ATC kód:

L01BB05

Léková forma:

POWDER FOR SOLUTION FOR INJ/INF

Podání:

I.V

Výrobce:

GENZYME EUROPE B.V., NETHERLANDS

Terapeutické skupiny:

FLUDARABINE

Terapeutické indikace:

Palliative treatment of patients with CLL refractory to other therapy. Treatment of less malignant Non-Hodgkin lymphoma of stage 3 to 4 in patients who have not responded to standard therapy with at least one alkylating agent or in whom the disease progressed during or after standard therapy. Fludara is indicated for the initial treatment of patients with B- cell chronic lymphocytic leukaemia (CLL) or after first line therapy, in patients with sufficient bone marrow reserves.

Datum autorizace:

2009-02-01